SMO ClinPlus Co. Ltd. (301257) — Capital Reinvestment Ratio
Latest as of December 2025:
0.22x
SMO ClinPlus Co. Ltd. (301257) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥35.69 Million) in capital expenditures (CN¥7.83 Million). See SMO ClinPlus Co. Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.22x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥35.69 Million
CNY
Capital Expenditures
CN¥7.83 Million
CNY
Data as of
Dec 2025
Most recent filing
SMO ClinPlus Co. Ltd. Capital Reinvestment Ratio (2019–2025)
This chart tracks SMO ClinPlus Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for SMO ClinPlus Co. Ltd. (2019–2025)
Year-by-year Capital Reinvestment Ratio for SMO ClinPlus Co. Ltd. from 2019 to 2025. For live market cap and broader valuation context, see how much is SMO ClinPlus Co. Ltd. worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥35.69 Million | CN¥7.83 Million | ▲ +146.0% |
| 2023 | 0.09x | CN¥114.85 Million | CN¥10.25 Million | ▼ -54.6% |
| 2022 | 0.20x | CN¥40.44 Million | CN¥7.95 Million | ▲ +85.4% |
| 2021 | 0.11x | CN¥41.52 Million | CN¥4.40 Million | ▼ -41.7% |
| 2020 | 0.18x | CN¥22.45 Million | CN¥4.08 Million | ▲ +68.6% |
| 2019 | 0.11x | CN¥45.53 Million | CN¥4.91 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow